Pictet Asset Management Holding Sa Crispr Therapeutics Ag Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 250,290 shares of CRSP stock, worth $11.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
250,290
Previous 190,408
31.45%
Holding current value
$11.8 Million
Previous $10.3 Million
14.37%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
491Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$372 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$352 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$141 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$139 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$139 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.66B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....